Meningitis caused by Candida albicans in a premature neonate

Baradkar, Vasant P.; Taklikar, Shripad M.
July 2007
Journal of Pediatric Neurosciences;Jul-Dec2007, Vol. 2 Issue 2, p90
Academic Journal
Case Study
The article presents a case study of a premature male neonate who was admitted to neonatal intensive care unit (NICU) with candidial meningitis. Amphotericin B was administered to the patient based on clinical suspicion, cerebrospinal fluid (CSF) abnormalities and isolation of Candida albicans from blood specimens. It provides the criteria for diagnosis of candidial meningitis. The authors emphasize the need for high index of suspicion to diagnose a patient so that early intervention of amphotericin B will be made to reduce mortality.


Related Articles

  • A case series of the management of symptomatic azole-resistant candida. Challenor, R.; Pinsent, S.; Ekanayaka, R. // International Journal of STD & AIDS;May2012, Vol. 23 Issue 5, p375 

    Patients with symptomatic azole-resistant Candida albicans or non-albicans candida are difficult to manage. Treatment is largely anecdotal due to the relatively small number of patients. We present six case reports which highlight our own observation in clinical practice including four patients...

  • Host Immune Reactivity Determines the Efficacy of Combination Immunotherapy and Antifungal Chemotherapy in Candidiasis. Mencacci, Antonella; Cenci, Elio; Bacci, Angela; Bistoni, Francesco; Romani, Luigina // Journal of Infectious Diseases;2/1/2000, Vol. 181 Issue 2, p686 

    Assesses the immunomodulatory functions of amphotericin B and fluconazole, either alone or combined with cytokines or cytokine antagonists in differently immunocompromised mice infected with Candida albicans. Factors affecting the development and regulation of the different T helper responses...

  • Worsening of Endogenous Candida albicans Endophthalmitis During Therapy with Intravenous Lipid... Virata, Steven R.; Kylstra, Jan A.; Brown, Justin C.; Wohl, David A.; Cohen, Myron S. // Clinical Infectious Diseases;5/1/1999, Vol. 28 Issue 5, p1177 

    Describes a patient with endogenous Candida albicans endophthalmitis that progressed after intravenous antifungal therapy was changed from fluconazole to lipid complex amphotericin B. Clinical diagnosis; Medical treatment; Efficacy of intravenous amphotericin B in treating C. albicans...

  • Characterization of the inhibitory effect of voriconazole on the fungicidal activity of amphotericin B against Candida albicans in an in vitro kinetic model. Anders Lignell; Elisabeth Löwdin; Otto Cars; Jan Sjölin // Journal of Antimicrobial Chemotherapy (JAC);Jul2008, Vol. 62 Issue 1, p142 

    Objectives The aim of the present investigation was to study and characterize the effect of voriconazole on the fungicidal activity of amphotericin B. Methods Four strains of Candida albicans susceptible to voriconazole were exposed to voriconazole and amphotericin B, either alone,...

  • A neonatal case from the land of shadows. Brien, James H. // Infectious Diseases in Children;Apr2012, Vol. 25 Issue 4, p28 

    The article describes a case of Ureaplasma urealyticum meningitis in a 9-day-old premature male infant.

  • Candidal infections of ventriculoperitoneal shunts. Baradkar, V. P.; Mathur, M.; Sonavane, A.; Kumar, S. // Journal of Pediatric Neurosciences;Jul-Sep2009, Vol. 4 Issue 2, p73 

    Although ventriculoperitoneal (VP) shunt infection is a common complication of shunt procedures, fungal infection is considered to be rare. In the present study, we performed retrospective analysis of six cases in which candida infection occurred. In all these six cases, VP shunt was performed...

  • In vitro activity of antifungal combinations against Candida albicans biofilms. Tobudic, Selma; Kratzer, Christina; Lassnigg, Andrea; Graninger, Wolfgang; Presterl, Elisabeth // Journal of Antimicrobial Chemotherapy (JAC);Feb2010, Vol. 65 Issue 2, p271 

    Objectives: The aim of the present study was to evaluate the in vitro activity and synergism of the combinations of amphotericin B/caspofungin and amphotericin B/posaconazole against Candida albicans, grown either as planktonic cells or in biofilms.

  • Study of Renal Toxicity in Wistar Rats Following the Action of Amphotericin B Solution Prepared under Extreme pH Conditions. Belkherroubi-Sari, Lamia; Boucherit, Zahia; Boucherit, Kebir; Belbraouet, Slimane // Food & Nutrition Sciences;Sep2011, Vol. 2 Issue 7, p731 

    Our study related to the renal toxicity of Wistar rats induced by solutions of amphotericin B prepared under extreme conditions of pH (5.4 and 10.8). The results obtained show that with pH 5.4 of stock solution, urea and creatinin rate blood is not disturbed. These means that the renal function...

  • Voriconazole Treatment of Candidemia.  // Clinical Infectious Diseases;2/15/2006, Vol. 42 Issue 4, preceding p441 

    The article presents information on a study on the use of voriconazole for the treatment of candidaemia in non-neutropenic patients. For the study Candida species other than Candida albicans were isolated in 43% and 48% of subjects, respectively. For each group the median time to a negative...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics